Total Payments
$1,379
2024 Payments
$491.61
Companies
22
Transactions
52
Medicare Patients
1,705
Medicare Billing
$295,694
Payment Breakdown by Category
Food & Beverage$1,188 (86.1%)
Education$191.48 (13.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,188 | 48 | 86.1% |
| Education | $191.48 | 4 | 13.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $183.47 | 3 | $0 (2024) |
| PROGENICS PHARMACEUTICALS, INC. | $147.13 | 2 | $0 (2024) |
| Celgene Corporation | $121.06 | 5 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $114.18 | 5 | $0 (2023) |
| ABBVIE INC. | $96.99 | 5 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $96.31 | 5 | $0 (2024) |
| Merck Sharp & Dohme LLC | $90.78 | 4 | $0 (2024) |
| Janssen Biotech, Inc. | $76.62 | 3 | $0 (2024) |
| Tempus AI, Inc | $70.84 | 3 | $0 (2024) |
| Amgen Inc. | $63.57 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $491.61 | 18 | PROGENICS PHARMACEUTICALS, INC. ($124.16) |
| 2023 | $596.15 | 26 | Celgene Corporation ($121.06) |
| 2022 | $100.01 | 4 | E.R. Squibb & Sons, L.L.C. ($33.75) |
| 2021 | $175.06 | 3 | Astellas Pharma US Inc ($163.99) |
| 2020 | $16.42 | 1 | AstraZeneca Pharmaceuticals LP ($16.42) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/20/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Oncology | ||||||
| 08/21/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $29.87 | General |
| 08/06/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $124.16 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/05/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: ONCOLOGY | ||||||
| 07/31/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: ONCOLOGY | ||||||
| 07/24/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: NONE | ||||||
| 07/09/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: ONCOLOGY | ||||||
| 07/03/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $23.53 | General |
| 06/19/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Oncology | ||||||
| 05/30/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: ONCOLOGY | ||||||
| 05/22/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $13.17 | General |
| 05/22/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: ONCOLOGY | ||||||
| 04/16/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: Oncology | ||||||
| 03/12/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.70 | General |
| Category: Oncology | ||||||
| 02/28/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Oncology | ||||||
| 02/16/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $27.01 | General |
| 01/08/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Oncology | ||||||
| 10/24/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Oncology | ||||||
| 10/17/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.65 | General |
| Category: Oncology | ||||||
| 10/05/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $22.97 | General |
| Category: Hematology | ||||||
| 09/26/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $26.03 | General |
| Category: Hematology | ||||||
| 09/12/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $13.34 | General |
| Category: Hematology/Oncology | ||||||
| 09/06/2023 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 345 | 695 | $191,289 | $69,519 |
| 2022 | 5 | 413 | 681 | $188,219 | $60,941 |
| 2021 | 7 | 466 | 917 | $236,709 | $97,586 |
| 2020 | 8 | 481 | 827 | $181,238 | $67,649 |
Total Patients
1,705
Total Services
3,120
Medicare Billing
$295,694
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 180 | 474 | $124,036 | $45,447 | 36.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 54 | 97 | $35,413 | $13,249 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 80 | $14,736 | $4,866 | 33.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 20 | 20 | $9,022 | $3,241 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $8,082 | $2,717 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 157 | 356 | $96,476 | $32,966 | 34.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 82 | 121 | $32,791 | $8,772 | 26.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 35 | 45 | $17,010 | $6,136 | 36.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 67 | $12,797 | $3,854 | 30.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 19 | 19 | $8,778 | $3,169 | 36.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 19 | 25 | $9,450 | $2,728 | 28.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 34 | 37 | $7,067 | $1,874 | 26.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,850 | $1,441 | 37.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 197 | 555 | $135,799 | $55,771 | 41.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 72 | 136 | $44,568 | $19,622 | 44.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 107 | 130 | $21,773 | $8,252 | 37.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 45 | 45 | $20,006 | $8,228 | 41.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $6,565 | $2,363 | 36.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 14 | $5,910 | $2,198 | 37.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 12 | 18 | $2,088 | $1,153 | 55.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 194 | 461 | $105,569 | $37,884 | 35.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 124 | 163 | $25,428 | $9,138 | 35.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 33 | 51 | $15,606 | $6,236 | 40.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 29 | 29 | $12,586 | $4,520 | 35.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 50 | 70 | $8,120 | $4,301 | 53.0% |
About Dr. Angela Taber, MD
Dr. Angela Taber, MD is a Hematology healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1912124454.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Angela Taber, MD has received a total of $1,379 in payments from pharmaceutical and medical device companies, with $491.61 received in 2024. These payments were reported across 52 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,188).
As a Medicare-enrolled provider, Taber has provided services to 1,705 Medicare beneficiaries, totaling 3,120 services with total Medicare billing of $295,694. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Internal Medicine, Hematology & Oncology
- Location Providence, RI
- Active Since 04/19/2007
- Last Updated 02/19/2025
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1912124454
Products in Payments
- PYLARIFY (Drug) $147.13
- KEYTRUDA (Biological) $90.78
- REBLOZYL (Biological) $78.12
- IMBRUVICA (Drug) $67.47
- OPDIVO (Biological) $51.49
- LYNPARZA (Drug) $49.14
- EPANOVA (Drug) $48.62
- LONSURF (Drug) $41.95
- CABOMETYX (Drug) $39.99
- PADCEV (Biological) $36.16
- Pomalyst (Drug) $34.04
- BRUKINSA (Drug) $29.11
- XTANDI (Drug) $28.52
- Enhertu (Drug) $27.68
- ERLEADA (Drug) $26.86
- Kyprolis (Drug) $25.93
- ORGOVYX (Drug) $24.48
- CARVYKTI (Drug) $22.35
- Nubeqa (Drug) $20.12
- OPDUALAG (Drug) $19.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Providence
William Sikov, Md, MD
Hematology — Payments: $214,835
Hematology $214,835
Kimberly Perez
Hematology — Payments: $146,048
Hematology $146,048
Wafik El Deiry, Md, MD
Hematology — Payments: $3,821
Hematology $3,821
Dr. Jeremy Warner, Md, MD
Hematology — Payments: $2,900
Hematology $2,900
Sherise Rogers, M.d, M.D
Hematology — Payments: $375.85
Hematology $375.85
Mirela Stancu, M.d, M.D
Hematology — Payments: $226.97
Hematology $226.97